Grifols Wins Early FDA OK For SCIg Xembify, Setting Stage For Margin Growth

 
• By Sten Stovall
  
Syringe
Self-Injectable Immunoglobulins treat primary and secondary immunodeficiencies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip